SSA
BNTX icon

Schonfeld Strategic Advisors’s BioNTech BNTX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-45,000
Closed -$4.44M – 2076
2025
Q3 		$4.44M Buy
+45,000
New +$4.81M 0.03% 636

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Schonfeld Strategic Advisors's BNTX Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 23,078 shares — an estimated $2.2M sold.

Schonfeld Strategic Advisors first reported a position in BNTX in Q2 2020 and held it in 10 quarters. The position peaked at $8.82M in Q2 2023. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 23,078 BioNTech shares in Q1 2026, an estimated $2.2M.
  • Schonfeld Strategic Advisors first reported a position in BioNTech in Q2 2020 and held it in 10 quarters.
  • Schonfeld Strategic Advisors's BioNTech position peaked at $8.82M in Q2 2023.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.